About Kobo Biotech Ltd 
Kobo Biotech Ltd
Micro Cap
Commodity Chemicals
Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992. Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited. The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).
Capital Structure 
Present Equity Capital
INR 23.52 Cr
Number of Shares
2.35 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Apr-2016
2.35
23.52
100000
10
Conversion of Warrants
11-Apr-2016
2.35
23.52
100000
10
Conversion of Warrants
08-Dec-2015
2.34
23.43
100000
10
Conversion of Warrants
08-Dec-2015
2.34
23.43
100000
10
Conversion of Warrants
27-Nov-2015
2.33
23.32
100000
10
Conversion of Warrants
27-Nov-2015
2.33
23.32
100000
10
Conversion of Warrants
06-Nov-2015
2.32
23.23
100000
10
Conversion of Warrants
06-Nov-2015
2.32
23.23
100000
10
Conversion of Warrants
04-Nov-2015
2.31
23.12
300000
10
Conversion of Warrants
04-Nov-2015
2.31
23.12
300000
10
Conversion of Warrants
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Arch Pharmalabs Ltd (44.95%)
Highest Public shareholder
Mehul Pravin Chandra Shah (1.1%)
Individual Investors Holdings
48.27%
Management
Designation
Remuneration
Ajit Kamath
Chairman (Non-Executive)
0
Rajendra Kaimal
Non-Exec & Non-Independent Dir
0
Jignesh Patel
Company Sec. & Compli. Officer
0
Sunil Pitroda
Non-Exec. & Independent Dir.
0
Abhishek Buddhadev
Non-Exec. & Independent Dir.
0
Urja Shah
Non-Exec. & Independent Dir.
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Intermediates & APIs
32.54
99.64%
Intermediates & APIs
Intermediates & APIs
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2024)
Net Profit:
-1 Cr
Commodity Chemicals
INR 5 Cr (Micro Cap)
NA (Loss Making)
40
0.00%
-1.05
3.71%
-0.04






